Coronavirus Infection

Coronavirus infection in veterinary medicine refers to diseases caused by viruses belonging to the family Coronaviridae, genus Alphacoronavirus or Betacoronavirus. In dogs, the primary enteric pathogen is Canine Coronavirus (CCoV), which causes mild to moderate gastroenteritis, particularly in puppies. In cats, Feline Coronavirus (FCoV) can cause either a mild enteric infection or, in a subset of cats, a fatal systemic disease known as Feline Infectious Peritonitis (FIP). Other coronaviruses, such as Canine Respiratory Coronavirus (CRCoV) and SARS-CoV-2 (which can infect cats, dogs, and other animals), have also been identified. The disease is characterized by viral replication in the intestinal epithelium (enteric forms) or in macrophages (FIP), leading to clinical signs ranging from transient diarrhea to severe systemic inflammation and effusive or non-effusive disease.

The primary causative agents are: - Canine Coronavirus (CCoV): An Alphacoronavirus, with two genotypes (CCoV-I and CCoV-II). CCoV-II is more pathogenic and includes subtypes such as CCoV-IIa and CCoV-IIb (which may have recombinant origins). - Feline Coronavirus (FCoV): An Alphacoronavirus, with two serotypes (I and II). FCoV is ubiquitous in multi-cat environments. Mutations in the spike protein or other genes can lead to the biotype Feline Infectious Peritonitis Virus (FIPV), which has tropism for macrophages. - Canine Respiratory Coronavirus (CRCoV): A Betacoronavirus, related to bovine coronavirus and human OC43, associated with canine infectious respiratory disease complex (CIRDC). - SARS-CoV-2: A Betacoronavirus, primarily a human pathogen, but can infect cats, dogs, ferrets, and other animals, usually causing mild or subclinical respiratory or gastrointestinal signs. Transmission is primarily fecal-oral for enteric coronaviruses, and respiratory droplets for respiratory forms. The virus is enveloped, making it relatively labile in the environment, but it can survive in organic material for days. Replication occurs in the cytoplasm of enterocytes or respiratory epithelial cells, leading to cell lysis and villous atrophy.

Canine Coronavirus is distributed worldwide, with high seroprevalence in kennels and shelters. Puppies under 6 months are most susceptible, and infection is more common in crowded, stressful environments. Feline Coronavirus is endemic in multi-cat households and catteries, with up to 90% seropositivity in such settings. FIP occurs in 5-10% of FCoV-infected cats, with higher incidence in purebred cats, young cats (under 2 years), and those with genetic susceptibility. CRCoV is prevalent in dog populations, particularly in boarding kennels, and contributes to kennel cough. SARS-CoV-2 infections in animals are rare and typically associated with close contact with infected humans. No breed or sex predilection is significant for enteric coronaviruses, but FIP has been reported more in certain breeds (e.g., Abyssinian, Bengal, Birman, Persian). Seasonality is not pronounced, but stress and overcrowding increase transmission.

For enteric coronaviruses (CCoV, FCoV enteric form): The virus is ingested and infects mature enterocytes on the tips of intestinal villi. Replication causes cell lysis, leading to villous atrophy, crypt hyperplasia, and malabsorption. This results in diarrhea, often with mucus and occasional blood. The infection is usually self-limiting, with recovery in 3-7 days, but in young or immunocompromised animals, it can be more severe, leading to dehydration and electrolyte imbalances. Systemic spread is rare for CCoV, but FCoV can spread to macrophages. In FIP, the mutated FIPV replicates in macrophages, leading to systemic vasculitis and granulomatous inflammation. The virus induces an immune-mediated response, with type III hypersensitivity (immune complex deposition) and T-cell dysregulation. Effusive (wet) FIP results from vasculitis and increased vascular permeability, leading to protein-rich effusions in body cavities. Non-effusive (dry) FIP is characterized by granulomatous lesions in various organs, including the eyes, kidneys, liver, and central nervous system. The pathogenesis of FIP is complex, involving viral mutation, host immune response, and genetic factors.

Intrinsic factors: Age (young animals are more susceptible), immunocompromised status (e.g., FIV, FeLV in cats), genetic predisposition (certain cat breeds for FIP), and stress. Extrinsic factors: Overcrowding, poor sanitation, high population density (kennels, shelters, catteries), co-infections (e.g., canine parvovirus, feline panleukopenia), and environmental stress. For FIP, stress, early weaning, and high viral load in the environment are risk factors. For SARS-CoV-2, close contact with infected humans is the primary risk.

Canine Coronavirus: Often subclinical. In puppies, signs include acute onset of diarrhea (may be watery, mucoid, or bloody), vomiting, anorexia, lethargy, and mild fever. Dehydration can occur but is usually not severe. Respiratory signs are uncommon. Canine Respiratory Coronavirus: Cough, nasal discharge, and mild respiratory distress, often as part of CIRDC. Feline Coronavirus enteric form: Mild, self-limiting diarrhea, especially in kittens. Feline Infectious Peritonitis: Two forms. Effusive (wet) FIP: Fever, lethargy, anorexia, weight loss, abdominal distension due to ascites, and/or pleural effusion causing dyspnea. Non-effusive (dry) FIP: Chronic fever, weight loss, depression, and organ-specific signs such as uveitis, renal enlargement, neurological signs (ataxia, seizures), and granulomatous lesions. SARS-CoV-2 in animals: Usually subclinical or mild respiratory/gastrointestinal signs.

For enteric coronaviruses: Canine parvovirus, canine distemper, salmonellosis, giardiasis, coccidiosis, dietary indiscretion, inflammatory bowel disease, intestinal intussusception, and toxin exposure. For FIP: Feline panleukopenia, toxoplasmosis, feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), bacterial peritonitis, lymphoma, and other causes of effusions (e.g., cardiac failure, hypoalbuminemia). For respiratory coronaviruses: Canine adenovirus type 2, canine parainfluenza virus, Bordetella bronchiseptica, Mycoplasma spp., and other respiratory pathogens. Key distinguishing features: Parvovirus causes severe leukopenia and hemorrhagic diarrhea; FIP has characteristic effusions with low cellularity and high protein; bacterial peritonitis has septic exudate; lymphoma may show atypical lymphocytes.

1. History and physical examination: Assess vaccination status, environment, and clinical signs. 2. Fecal analysis for enteric coronaviruses: PCR on fecal samples is the most sensitive and specific test. Electron microscopy can detect viral particles but is less practical. 3. For FIP: Perform a combination of tests. Serum biochemistry and hematology may show hyperglobulinemia, hypoalbuminemia, and lymphopenia. Rivalta test on effusion fluid is a useful screening test (positive in FIP). PCR on effusion fluid or tissue for FCoV RNA can be supportive, but a positive PCR does not confirm FIP. Immunohistochemistry on biopsy or necropsy samples is the gold standard. 4. For respiratory coronaviruses: PCR on nasal or oropharyngeal swabs. 5. For SARS-CoV-2: PCR on nasal or rectal swabs, and serology. 6. Imaging (radiography, ultrasound) to assess effusions or organomegaly. 7. Rule out other causes with appropriate tests (e.g., parvovirus antigen test, FeLV/FIV tests).

Hematology: In enteric coronavirus, CBC may be normal or show mild lymphopenia. In FIP, common findings include lymphopenia, neutrophilia with left shift, and mild anemia. Biochemistry: In FIP, hyperglobulinemia (often >5 g/dL), hypoalbuminemia, increased alpha-2 and gamma globulins, and elevated liver enzymes (ALT, ALP) may be seen. In severe enteric infections, electrolyte imbalances (hyponatremia, hypokalemia) and metabolic acidosis may occur. Urinalysis: Usually unremarkable, but proteinuria may be present in FIP. Blood gas analysis: May show metabolic acidosis in dehydrated animals. Specific biomarkers: Serum amyloid A (SAA) is often elevated in FIP. Alpha-1 acid glycoprotein (AGP) is also elevated. PCR: Detection of viral RNA in feces, blood, effusion, or tissues. Serology: Antibody titers to FCoV are not diagnostic for FIP, as many healthy cats are seropositive. However, high titers (>1:1600) may increase suspicion.

Radiography: In FIP with effusions, thoracic radiographs may show pleural effusion (lung lobe retraction, fissure lines) and abdominal radiographs may show loss of serosal detail due to ascites. In enteric coronavirus, radiographs are usually unremarkable. Ultrasonography: In FIP, abdominal ultrasound may reveal ascites, mesenteric lymphadenopathy, hepatomegaly, renomegaly, and irregular kidney contours. In dry FIP, granulomatous lesions may appear as hyperechoic or hypoechoic masses. Echocardiography: Not typically indicated unless cardiac disease is suspected. CT/MRI: May be useful for neurological FIP to detect hydrocephalus or granulomas. Endoscopy: Not commonly used, but may be performed to obtain intestinal biopsies in chronic diarrhea.

Cytology: Effusion fluid in FIP is typically a modified transudate or exudate with high protein content (>3.5 g/dL), low cellularity (predominantly macrophages and neutrophils), and may form a clot on standing. Rivalta test is positive. Histopathology: In FIP, characteristic lesions include pyogranulomatous inflammation with vasculitis, perivascular cuffing, and necrosis. Immunohistochemistry for FCoV antigen is confirmatory. In enteric coronavirus, intestinal biopsies may show villous atrophy and crypt hyperplasia, but are rarely performed.

Enteric coronaviruses: Supportive care is the mainstay. Fluid therapy with balanced electrolyte solutions (e.g., lactated Ringer's) to correct dehydration and electrolyte imbalances. Anti-emetics (e.g., maropitant 1 mg/kg SC q24h) if vomiting. Antidiarrheals are generally not recommended. Nutritional support with a highly digestible diet. Antibiotics are not indicated unless secondary bacterial infection is suspected. FIP: Historically fatal, but recent advances have shown efficacy with antiviral drugs. GS-441524 (remdesivir derivative) has shown promise, but is not yet licensed in many countries. Supportive care includes fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids (e.g., prednisolone 1-2 mg/kg PO q24h) to reduce inflammation. Effusions may be drained for comfort, but repeated drainage can lead to protein loss. For respiratory coronaviruses: Supportive care, including rest, hydration, and possibly antibiotics for secondary bacterial infections. For SARS-CoV-2: No specific treatment required; supportive care.

Enteric coronaviruses: Excellent prognosis, with most animals recovering within a week. Severe disease can occur in young puppies with concurrent infections, but mortality is low. FIP: Historically poor, with a median survival time of weeks to months. With antiviral therapy (GS-441524), survival rates have improved significantly, with some studies showing >80% recovery. Prognosis is better for effusive FIP than non-effusive. Respiratory coronaviruses: Good prognosis, with recovery in 1-2 weeks. SARS-CoV-2: Excellent prognosis, with most animals recovering without treatment.

For enteric coronaviruses: Recheck in 3-5 days if symptoms persist. Monitor hydration status and body weight. For FIP: If treated with antivirals, monitor clinical signs, bloodwork (globulins, albumin, SAA) weekly initially, then monthly. Repeat imaging to assess effusion resolution. For respiratory coronaviruses: Recheck in 1-2 weeks. For SARS-CoV-2: No specific follow-up required, but isolate from other animals and humans.

Pearls: In FIP, a positive Rivalta test on effusion fluid is highly suggestive. Hyperglobulinemia with hypoalbuminemia in a young cat with fever and effusion is classic. Antiviral therapy (GS-441524) is a game-changer for FIP. Pitfalls: Do not diagnose FIP based solely on positive FCoV antibody titers. Do not use corticosteroids as sole therapy for FIP. In enteric coronavirus, do not overuse antibiotics. Always rule out parvovirus in puppies with diarrhea.

For FIP: GS-441524 (not licensed in many countries, but available through compounding pharmacies): 4 mg/kg SC q24h for 12 weeks, or 10 mg/kg for neurological/ocular FIP. Remdesivir (human drug) has been used off-label: 10 mg/kg IV q24h for 12 weeks. Supportive: Prednisolone 1-2 mg/kg PO q24h, tapering. Maropitant 1 mg/kg SC q24h for vomiting. For enteric coronavirus: Fluid therapy: Lactated Ringer's solution, 60-100 mL/kg/day IV or SC, adjusted based on hydration. Maropitant 1 mg/kg SC q24h. For secondary bacterial infections: Amoxicillin-clavulanate 12.5-25 mg/kg PO q12h. For respiratory coronavirus: Doxycycline 5-10 mg/kg PO q12h for 7-10 days if Mycoplasma is suspected. All dosages per Plumb's Veterinary Drug Handbook.

Key studies: Pedersen et al. (2019) demonstrated efficacy of GS-441524 in treating FIP, with 18/31 cats cured. Addie et al. (2015) published consensus guidelines on FIP diagnosis and management. For canine coronavirus, studies show that CCoV is often co-infecting with parvovirus, leading to more severe disease. ACVIM consensus statements on infectious diseases emphasize the importance of PCR for diagnosis and the limited role of serology. Recent research on SARS-CoV-2 in animals indicates low susceptibility and no evidence of animal-to-human transmission.